ONTOLOGY REPORT - ANNOTATIONS
| Term: | methylmercury chloride |
|
| Accession: | CHEBI:28216
|
browse the term
|
| Definition: | A chlorine molecular entity that has formula CH3ClHg. |
| Synonyms: | exact_synonym: | chloro(methyl)mercury |
| | related_synonym: | CH3ClHg; CH3HgCl; C[Hg]Cl; InChI=1S/CH3.ClH.Hg/h1H3;1H;/q;;+1/p-1; InChIKey=BABMCXWQNSQAOC-UHFFFAOYSA-M; MeHgCl; [HgClMe]; chloromethylmercury; mercury methyl chloride; methylmercuric chloride; monomethylmercury chloride |
| | alt_id: | CHEBI:25321; CHEBI:6883 |
| | xref_casrn: | 115-09-3 |
| | xref: | ChEBI:c0092 "UM-BBD compID"; ChEMBL:1098058 "ChEMBL COMPOUND"; ChemIDplus:115-09-3 "CAS Registry Number"; ChemIDplus:3600218 "Beilstein Registry Number"; Gmelin:1932 "Gmelin Registry Number"; KEGG COMPOUND:115-09-3 "CAS Registry Number"; KEGG COMPOUND:C11146 "KEGG COMPOUND" |
| | xref_mesh: | MESH:C004925 |
| | xref: | NIST Chemistry WebBook:115-09-3 "CAS Registry Number" |
|
|
methylmercury chloride
|
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
increases expression |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abr |
active BCR-related |
|
affects expression |
EXP |
10 |
67,617,776 |
67,760,961 |
RGD:6480464 |
CTD |
| G |
Adarb1 |
adenosine deaminase, RNA-specific, B1 |
|
decreases expression |
EXP |
20 |
11,616,718 |
11,747,294 |
RGD:6480464 |
CTD |
| G |
Agrn |
agrin |
|
affects expression |
EXP |
5 |
172,999,420 |
173,020,764 |
RGD:6480464 |
CTD |
| G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
|
increases expression |
ISO |
17 |
77,269,626 |
77,286,521 |
RGD:6480464 |
CTD |
| G |
Aktip |
AKT interacting protein |
|
decreases expression |
ISO |
19 |
17,035,220 |
17,045,096 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
multiple interactions |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alcam |
activated leukocyte cell adhesion molecule |
|
affects expression |
ISO |
11 |
49,424,243 |
49,630,071 |
RGD:6480464 |
CTD |
| G |
Aldh9a1 |
aldehyde dehydrogenase 9 family, member A1 |
|
increases expression |
EXP |
13 |
83,017,312 |
83,034,047 |
RGD:6480464 |
CTD |
| G |
Ankrd37 |
ankyrin repeat domain 37 |
|
decreases expression |
EXP |
16 |
49,549,527 |
49,552,416 |
RGD:6480464 |
CTD |
| G |
Arc |
activity-regulated cytoskeleton-associated protein |
|
increases expression |
ISO |
7 |
112,771,937 |
112,775,381 |
RGD:6480464 |
CTD |
| G |
Arg2 |
arginase type II |
|
increases expression |
ISO |
6 |
101,901,653 |
101,928,282 |
RGD:6480464 |
CTD |
| G |
Arih2 |
ariadne homolog 2 (Drosophila) |
|
increases expression |
ISO |
8 |
113,647,000 |
113,705,922 |
RGD:6480464 |
CTD |
| G |
Arrb2 |
arrestin, beta 2 |
|
increases expression |
EXP |
10 |
57,244,071 |
57,284,166 |
RGD:6480464 |
CTD |
| G |
Aspm |
asp (abnormal spindle) homolog, microcephaly associated (Drosophila) |
|
decreases expression |
ISO |
13 |
52,811,658 |
52,860,925 |
RGD:6480464 |
CTD |
| G |
Aspm |
asp (abnormal spindle) homolog, microcephaly associated (Drosophila) |
|
affects expression |
EXP |
13 |
52,811,658 |
52,860,925 |
RGD:6480464 |
CTD |
| G |
Atf2 |
activating transcription factor 2 |
|
increases expression |
ISO |
3 |
56,403,676 |
56,496,473 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
increases expression |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atpaf1 |
ATP synthase mitochondrial F1 complex assembly factor 1 |
|
decreases expression |
EXP |
5 |
136,049,177 |
136,075,532 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Boc |
BOC cell adhesion associated, oncogene regulated |
|
affects expression |
ISO |
11 |
57,668,326 |
57,710,373 |
RGD:6480464 |
CTD |
| G |
Boc |
BOC cell adhesion associated, oncogene regulated |
|
affects expression |
ISO |
11 |
57,668,326 |
57,710,373 |
RGD:6480464 |
CTD |
| G |
Btrc |
beta-transducin repeat containing E3 ubiquitin protein ligase |
|
decreases expression |
ISO |
1 |
250,528,730 |
250,693,952 |
RGD:6480464 |
CTD |
| G |
C2cd5 |
C2 calcium-dependent domain containing 5 |
|
increases expression |
EXP |
4 |
180,903,353 |
180,989,193 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cblc |
Cbl proto-oncogene, E3 ubiquitin protein ligase C |
|
decreases expression |
ISO |
1 |
79,091,412 |
79,108,189 |
RGD:6480464 |
CTD |
| G |
Ccdc174 |
coiled-coil domain containing 174 |
|
decreases expression |
EXP |
4 |
126,074,136 |
126,100,614 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
decreases expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
decreases expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1ip1 |
cyclin B1 interacting protein 1, E3 ubiquitin protein ligase |
|
affects expression |
ISO |
15 |
26,771,098 |
26,786,775 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
decreases expression |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
increases cleavage |
EXP |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
decreases expression |
EXP |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
decreases expression |
ISO |
5 |
25,032,748 |
25,044,509 |
RGD:6480464 |
CTD |
| G |
Ccnt1 |
cyclin T1 |
|
decreases expression |
ISO |
7 |
137,288,635 |
137,314,809 |
RGD:6480464 |
CTD |
| G |
Ccz1 |
CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae) |
|
decreases expression |
EXP |
12 |
10,929,886 |
10,953,939 |
RGD:6480464 |
CTD |
| G |
Cd200r1l |
CD200 receptor 1-like |
|
increases expression |
ISO |
11 |
57,345,447 |
57,397,038 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
increases expression |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
decreases expression |
ISO |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc25b |
cell division cycle 25B |
|
increases expression |
EXP |
3 |
118,893,716 |
118,903,516 |
RGD:6480464 |
CTD |
| G |
Cdc25b |
cell division cycle 25B |
|
decreases expression |
ISO |
3 |
118,893,716 |
118,903,516 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
decreases expression |
ISO |
18 |
27,206,537 |
27,225,811 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
decreases expression |
EXP |
5 |
156,106,123 |
156,143,040 |
RGD:6480464 |
CTD |
| G |
Cdca3 |
cell division cycle associated 3 |
|
decreases expression |
ISO |
4 |
160,952,986 |
160,956,574 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
affects expression |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases expression |
EXP |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
decreases expression |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
decreases expression |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
decreases methylation |
EXP |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
|
decreases expression |
ISO |
5 |
131,012,524 |
131,017,679 |
RGD:6480464 |
CTD |
| G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
|
decreases expression |
ISO |
15 |
22,617,409 |
22,624,922 |
RGD:6480464 |
CTD |
| G |
Cdx2 |
caudal type homeo box 2 |
|
affects expression |
EXP |
12 |
8,296,103 |
8,303,643 |
RGD:6480464 |
CTD |
| G |
Celsr1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
|
affects expression |
EXP |
7 |
123,900,366 |
124,036,122 |
RGD:6480464 |
CTD |
| G |
Cenpp |
centromere protein P |
|
decreases expression |
ISO |
17 |
20,969,057 |
21,145,366 |
RGD:6480464 |
CTD |
| G |
Cetn3 |
centrin, EF-hand protein, 3 |
|
decreases expression |
ISO |
2 |
9,909,950 |
9,922,361 |
RGD:6480464 |
CTD |
| G |
Chd7 |
chromodomain helicase DNA binding protein 7 |
|
affects expression |
EXP |
5 |
22,549,237 |
22,710,257 |
RGD:6480464 |
CTD |
| G |
Chek1 |
checkpoint kinase 1 |
|
decreases expression |
ISO |
8 |
37,954,322 |
37,974,748 |
RGD:6480464 |
CTD |
| G |
Chrna2 |
cholinergic receptor, nicotinic, alpha 2 (neuronal) |
|
decreases expression |
ISO |
15 |
45,570,809 |
45,587,091 |
RGD:6480464 |
CTD |
| G |
Chrna6 |
cholinergic receptor, nicotinic, alpha 6 (neuronal) |
|
decreases expression |
ISO |
16 |
69,012,201 |
69,018,901 |
RGD:6480464 |
CTD |
| G |
Chrnb3 |
cholinergic receptor, nicotinic, beta 3 (neuronal) |
|
decreases expression |
ISO |
16 |
69,028,625 |
69,069,274 |
RGD:6480464 |
CTD |
| G |
Chrne |
cholinergic receptor, nicotinic, epsilon (muscle) |
|
increases expression |
ISO |
10 |
57,497,192 |
57,501,511 |
RGD:6480464 |
CTD |
| G |
Chrng |
cholinergic receptor, nicotinic, gamma (muscle) |
|
decreases expression |
ISO |
9 |
86,012,089 |
86,018,199 |
RGD:6480464 |
CTD |
| G |
Coch |
coagulation factor C homolog, cochlin (Limulus polyphemus) |
|
decreases expression |
EXP |
6 |
71,692,946 |
71,697,056 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
affects expression |
EXP |
10 |
11,598,680 |
11,724,122 |
RGD:6480464 |
CTD |
| G |
Csnk2a2 |
casein kinase 2, alpha prime polypeptide |
|
decreases expression |
EXP |
19 |
10,015,369 |
10,054,662 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
affects expression |
EXP |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cyb5r3 |
cytochrome b5 reductase 3 |
|
decreases expression |
ISO |
7 |
121,187,821 |
121,205,382 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
affects expression |
EXP |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Cyp7b1 |
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
decreases expression |
EXP |
2 |
103,102,679 |
103,271,273 |
RGD:6480464 |
CTD |
| G |
Dcaf11 |
DDB1 and CUL4 associated factor 11 |
|
decreases expression |
EXP |
15 |
33,691,576 |
33,701,328 |
RGD:6480464 |
CTD |
| G |
Ddhd1 |
DDHD domain containing 1 |
|
increases expression |
EXP |
15 |
21,500,775 |
21,569,296 |
RGD:6480464 |
CTD |
| G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
|
affects expression |
EXP |
20 |
3,194,265 |
3,214,611 |
RGD:6480464 |
CTD |
| G |
Ddx31 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 31 |
|
decreases expression |
EXP |
3 |
7,849,554 |
7,914,005 |
RGD:6480464 |
CTD |
| G |
Ddx60 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 |
|
decreases expression |
ISO |
16 |
30,934,840 |
31,080,644 |
RGD:6480464 |
CTD |
| G |
Dlc1 |
deleted in liver cancer 1 |
|
affects expression |
ISO |
16 |
59,312,930 |
59,355,129 |
RGD:6480464 |
CTD |
| G |
Dll1 |
delta-like 1 (Drosophila) |
|
affects expression |
EXP |
1 |
54,240,395 |
54,248,183 |
RGD:6480464 |
CTD |
| G |
Dll3 |
delta-like 3 (Drosophila) |
|
affects expression |
EXP |
1 |
83,373,482 |
83,381,219 |
RGD:6480464 |
CTD |
| G |
Dmpk |
dystrophia myotonica-protein kinase |
|
decreases response to substance |
ISO |
1 |
78,449,324 |
78,450,578 |
RGD:6480464 |
CTD |
| G |
Dmpk |
dystrophia myotonica-protein kinase |
|
decreases response to substance |
ISO |
1 |
78,449,324 |
78,450,578 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
decreases expression |
EXP |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
decreases expression |
EXP |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dnmt3l |
DNA (cytosine-5-)-methyltransferase 3-like |
|
affects expression |
ISO |
20 |
10,958,957 |
10,973,422 |
RGD:6480464 |
CTD |
| G |
Dpysl4 |
dihydropyrimidinase-like 4 |
|
affects expression |
EXP |
1 |
198,866,034 |
198,881,902 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
decreases expression |
ISO |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
decreases expression |
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd3 |
dopamine receptor D3 |
|
decreases expression |
ISO |
11 |
58,446,901 |
58,520,589 |
RGD:6480464 |
CTD |
| G |
Dsg1 |
desmoglein 1 |
|
decreases expression |
ISO |
18 |
12,127,180 |
12,156,469 |
RGD:6480464 |
CTD |
| G |
Dtx4 |
deltex homolog 4 (Drosophila) |
|
decreases expression |
EXP |
1 |
215,396,194 |
215,416,879 |
RGD:6480464 |
CTD |
| G |
Dync2h1 |
dynein cytoplasmic 2 heavy chain 1 |
|
affects expression |
EXP |
8 |
3,826,843 |
4,072,644 |
RGD:6480464 |
CTD |
| G |
Ebpl |
emopamil binding protein-like |
|
decreases expression |
EXP |
15 |
40,484,464 |
40,506,451 |
RGD:6480464 |
CTD |
| G |
Eci1 |
enoyl-CoA delta isomerase 1 |
|
decreases expression |
EXP |
10 |
13,683,000 |
13,697,179 |
RGD:6480464 |
CTD |
| G |
Efnb3 |
ephrin B3 |
|
affects expression |
ISO |
10 |
56,373,322 |
56,379,316 |
RGD:6480464 |
CTD |
| G |
Ell |
elongation factor RNA polymerase II |
|
decreases expression |
EXP |
16 |
19,349,939 |
19,397,253 |
RGD:6480464 |
CTD |
| G |
Emc6 |
ER membrane protein complex subunit 6 |
|
decreases expression |
EXP |
10 |
60,052,329 |
60,053,594 |
RGD:6480464 |
CTD |
| G |
Emx2 |
empty spiracles homeobox 2 |
|
decreases expression |
ISO |
1 |
266,004,257 |
266,011,265 |
RGD:6480464 |
CTD |
| G |
Emx2 |
empty spiracles homeobox 2 |
|
decreases expression |
ISO |
1 |
266,004,257 |
266,011,265 |
RGD:6480464 |
CTD |
| G |
Endod1 |
endonuclease domain containing 1 |
|
decreases expression |
EXP |
8 |
11,151,051 |
11,180,463 |
RGD:6480464 |
CTD |
| G |
Epha2 |
Eph receptor A2 |
|
affects expression |
ISO |
5 |
160,185,143 |
160,214,727 |
RGD:6480464 |
CTD |
| G |
Esrrb |
estrogen-related receptor beta |
|
affects expression |
ISO |
6 |
110,589,116 |
110,635,158 |
RGD:6480464 |
CTD |
| G |
Esyt2 |
extended synaptotagmin-like protein 2 |
|
decreases expression |
EXP |
6 |
143,566,626 |
143,657,881 |
RGD:6480464 |
CTD |
| G |
Etv4 |
ets variant 4 |
|
affects expression |
EXP |
10 |
90,808,439 |
90,824,019 |
RGD:6480464 |
CTD |
| G |
Fabp7 |
fatty acid binding protein 7, brain |
|
affects expression |
EXP |
20 |
36,812,518 |
36,816,050 |
RGD:6480464 |
CTD |
| G |
Fastkd3 |
FAST kinase domains 3 |
|
decreases expression |
EXP |
17 |
5,077,472 |
5,086,004 |
RGD:6480464 |
CTD |
| G |
Fbln2 |
fibulin 2 |
|
increases expression |
EXP |
4 |
125,380,549 |
125,441,079 |
RGD:6480464 |
CTD |
| G |
Fbrs |
fibrosin |
|
increases expression |
EXP |
1 |
186,765,024 |
186,777,299 |
RGD:6480464 |
CTD |
| G |
Fdx1 |
ferredoxin 1 |
|
decreases expression |
EXP |
8 |
55,291,396 |
55,310,507 |
RGD:6480464 |
CTD |
| G |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
|
affects expression |
EXP |
8 |
38,078,328 |
38,123,983 |
RGD:6480464 |
CTD |
| G |
Fezf2 |
Fez family zinc finger 2 |
|
affects expression |
ISO |
15 |
14,350,796 |
14,354,585 |
RGD:6480464 |
CTD |
| G |
Fgf18 |
fibroblast growth factor 18 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fgf8 |
fibroblast growth factor 8 |
|
decreases expression |
ISO |
1 |
250,951,023 |
250,956,730 |
RGD:6480464 |
CTD |
| G |
Fgf8 |
fibroblast growth factor 8 |
|
affects expression |
EXP |
1 |
250,951,023 |
250,956,730 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
affects expression |
ISO |
16 |
70,869,974 |
70,910,045 |
RGD:6480464 |
CTD |
| G |
Fhl1 |
four and a half LIM domains 1 |
|
increases expression |
EXP |
X |
141,315,765 |
141,329,278 |
RGD:6480464 |
CTD |
| G |
Filip1l |
filamin A interacting protein 1-like |
|
increases expression |
EXP |
11 |
43,788,676 |
43,859,932 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
affects expression |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
increases expression |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Fuk |
fucokinase |
|
increases expression |
EXP |
19 |
40,803,644 |
40,823,587 |
RGD:6480464 |
CTD |
| G |
Gab1 |
GRB2-associated binding protein 1 |
|
affects expression |
ISO |
19 |
28,980,284 |
29,088,877 |
RGD:6480464 |
CTD |
| G |
Gabra1 |
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
|
decreases expression |
ISO |
10 |
27,258,813 |
27,313,725 |
RGD:6480464 |
CTD |
| G |
Gabra4 |
gamma-aminobutyric acid (GABA) A receptor, alpha 4 |
|
decreases expression |
ISO |
14 |
39,047,461 |
39,122,531 |
RGD:6480464 |
CTD |
| G |
Gabrd |
gamma-aminobutyric acid (GABA) A receptor, delta |
|
decreases expression |
EXP |
5 |
172,203,064 |
172,214,960 |
RGD:6480464 |
CTD |
| G |
Gabrq |
gamma-aminobutyric acid (GABA) A receptor, theta |
|
decreases expression |
ISO |
X |
158,843,492 |
158,855,961 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
decreases expression |
ISO |
3 |
52,789,370 |
52,830,038 |
RGD:6480464 |
CTD |
| G |
Gad2 |
glutamate decarboxylase 2 |
|
decreases expression |
ISO |
17 |
96,259,430 |
96,321,857 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
affects expression |
EXP |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
increases expression |
ISO |
7 |
10,289,073 |
10,291,102 |
RGD:6480464 |
CTD |
| G |
Galr2 |
galanin receptor 2 |
|
increases expression |
ISO |
10 |
106,394,006 |
106,396,171 |
RGD:6480464 |
CTD |
| G |
Galr3 |
galanin receptor 3 |
|
decreases expression |
ISO |
7 |
117,014,148 |
117,017,058 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
increases expression |
ISO |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Gdf10 |
growth differentiation factor 10 |
|
decreases expression |
EXP |
16 |
9,558,781 |
9,570,656 |
RGD:6480464 |
CTD |
| G |
Gdnf |
glial cell derived neurotrophic factor |
|
decreases expression |
ISO |
2 |
57,399,312 |
57,424,030 |
RGD:6480464 |
CTD |
| G |
Gjb5 |
gap junction protein, beta 5 |
|
affects expression |
ISO |
5 |
146,802,849 |
146,803,664 |
RGD:6480464 |
CTD |
| G |
Glra3 |
glycine receptor, alpha 3 |
|
decreases expression |
ISO |
16 |
37,741,192 |
37,854,773 |
RGD:6480464 |
CTD |
| G |
Gls |
glutaminase |
|
increases activity |
EXP |
9 |
46,380,165 |
46,452,974 |
RGD:6480464 |
CTD |
| G |
Gls |
glutaminase |
|
multiple interactions |
EXP |
9 |
46,380,165 |
46,452,974 |
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gnrh1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
multiple interactions |
EXP |
15 |
47,303,309 |
47,307,517 |
RGD:6480464 |
CTD |
| G |
Gnrh1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
affects secretion |
EXP |
15 |
47,303,309 |
47,307,517 |
RGD:6480464 |
CTD |
| G |
Gosr1 |
golgi SNAP receptor complex member 1 |
|
decreases expression |
EXP |
10 |
67,407,203 |
67,442,601 |
RGD:6480464 |
CTD |
| G |
Gpr114 |
G protein-coupled receptor 114 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
decreases expression |
ISO |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Gpx7 |
glutathione peroxidase 7 |
|
decreases expression |
ISO |
5 |
129,506,986 |
129,514,830 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
decreases expression |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
decreases expression |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
decreases expression |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
multiple interactions |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin2a |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
|
decreases expression |
EXP |
10 |
5,588,229 |
6,004,780 |
RGD:6480464 |
CTD |
| G |
Grin2a |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
|
decreases expression |
EXP |
10 |
5,588,229 |
6,004,780 |
RGD:6480464 |
CTD |
| G |
Grin2a |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
|
decreases expression |
EXP |
10 |
5,588,229 |
6,004,780 |
RGD:6480464 |
CTD |
| G |
Grin2a |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
|
multiple interactions |
EXP |
10 |
5,588,229 |
6,004,780 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
decreases expression |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
decreases expression |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grin2c |
glutamate receptor, ionotropic, N-methyl D-aspartate 2C |
|
increases expression |
EXP |
10 |
105,323,371 |
105,340,976 |
RGD:6480464 |
CTD |
| G |
Grpr |
gastrin releasing peptide receptor |
|
decreases expression |
EXP |
X |
51,743,248 |
51,783,255 |
RGD:6480464 |
CTD |
| G |
Grwd1 |
glutamate-rich WD repeat containing 1 |
|
decreases expression |
EXP |
1 |
96,301,559 |
96,307,145 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases expression |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
increases expression |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gss |
glutathione synthetase |
|
increases expression |
ISO |
3 |
146,057,517 |
146,087,820 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
ISO |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
increases expression |
ISO |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
increases expression |
ISO |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gstk1 |
glutathione S-transferase kappa 1 |
|
decreases expression |
ISO |
4 |
69,999,767 |
70,004,086 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
decreases activity |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
decreases expression |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gsto1 |
glutathione S-transferase omega 1 |
|
increases expression |
ISO |
1 |
253,228,547 |
253,238,531 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
affects response to substance |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
decreases expression |
ISO |
5 |
148,672,515 |
148,699,810 |
RGD:6480464 |
CTD |
| G |
Heca |
headcase homolog (Drosophila) |
|
increases expression |
EXP |
1 |
12,933,861 |
12,947,642 |
RGD:6480464 |
CTD |
| G |
Hes1 |
hairy and enhancer of split 1 (Drosophila) |
|
affects expression |
EXP |
11 |
72,603,482 |
72,605,673 |
RGD:6480464 |
CTD |
| G |
Hes3 |
hairy and enhancer of split 3 (Drosophila) |
|
affects expression |
EXP |
5 |
169,516,965 |
169,518,859 |
RGD:6480464 |
CTD |
| G |
Hes5 |
hairy and enhancer of split 5 (Drosophila) |
|
affects expression |
ISO |
5 |
171,763,869 |
171,764,636 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hoxb1 |
homeo box B1 |
|
increases expression |
ISO |
10 |
85,098,903 |
85,100,308 |
RGD:6480464 |
CTD |
| G |
Hoxb4 |
homeo box B4 |
|
decreases expression |
ISO |
10 |
85,050,695 |
85,053,277 |
RGD:6480464 |
CTD |
| G |
Hoxb4 |
homeo box B4 |
|
increases expression |
ISO |
10 |
85,050,695 |
85,053,277 |
RGD:6480464 |
CTD |
| G |
Hpgd |
hydroxyprostaglandin dehydrogenase 15 (NAD) |
|
affects expression |
EXP |
16 |
37,419,901 |
37,457,896 |
RGD:6480464 |
CTD |
| G |
Hrmt1l3 |
HMT1 hnRNP methyltransferase-like 3 (S. cerevisiae) |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
EXP |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb6 |
heat shock protein, alpha-crystallin-related, B6 |
|
increases expression |
EXP |
1 |
85,599,075 |
85,601,214 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
increases expression |
EXP |
5 |
154,934,138 |
154,935,707 |
RGD:6480464 |
CTD |
| G |
Idh1 |
isocitrate dehydrogenase 1 (NADP+), soluble |
|
decreases expression |
ISO |
9 |
63,769,401 |
63,790,622 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
affects expression |
EXP |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
increases expression |
EXP |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Il10rb |
interleukin 10 receptor, beta |
|
increases expression |
EXP |
11 |
31,381,317 |
31,397,079 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
decreases expression |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il4r |
interleukin 4 receptor |
|
increases expression |
EXP |
1 |
184,612,903 |
184,637,863 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases secretion |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Ino80c |
INO80 complex subunit C |
|
decreases expression |
EXP |
18 |
15,863,573 |
15,878,207 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
decreases expression |
ISO |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Irs2 |
insulin receptor substrate 2 |
|
affects expression |
EXP |
16 |
83,379,987 |
83,404,220 |
RGD:6480464 |
CTD |
| G |
Irx5 |
iroquois homeobox 5 |
|
affects expression |
ISO |
19 |
15,747,720 |
15,750,414 |
RGD:6480464 |
CTD |
| G |
Kctd14 |
potassium channel tetramerisation domain containing 14 |
|
decreases expression |
EXP |
1 |
154,686,321 |
154,691,235 |
RGD:6480464 |
CTD |
| G |
Kidins220 |
kinase D-interacting substrate 220 |
|
increases expression |
EXP |
6 |
42,649,878 |
42,740,157 |
RGD:6480464 |
CTD |
| G |
Kif5c |
kinesin family member 5C |
|
affects expression |
EXP |
3 |
30,602,210 |
30,755,482 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
affects secretion |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhx2 |
LIM homeobox 2 |
|
affects expression |
ISO |
3 |
18,129,455 |
18,147,357 |
RGD:6480464 |
CTD |
| G |
Lnx1 |
ligand of numb-protein X 1, E3 ubiquitin protein ligase |
|
decreases expression |
ISO |
14 |
35,888,702 |
35,992,436 |
RGD:6480464 |
CTD |
| G |
LOC100360497 |
G protein-coupled receptor 114-like |
|
increases expression |
ISO |
19 |
10,517,112 |
10,539,070 |
RGD:6480464 |
CTD |
| G |
Lrp4 |
low density lipoprotein receptor-related protein 4 |
|
affects expression |
EXP |
3 |
75,821,638 |
75,875,100 |
RGD:6480464 |
CTD |
| G |
Lysmd2 |
LysM, putative peptidoglycan-binding, domain containing 2 |
|
decreases expression |
EXP |
8 |
80,446,544 |
80,462,607 |
RGD:6480464 |
CTD |
| G |
Mafg |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) |
|
increases expression |
ISO |
10 |
110,019,741 |
110,024,927 |
RGD:6480464 |
CTD |
| G |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) |
|
increases expression |
ISO |
12 |
15,312,420 |
15,323,137 |
RGD:6480464 |
CTD |
| G |
Man2a1 |
mannosidase, alpha, class 2A, member 1 |
|
affects expression |
ISO |
9 |
103,302,748 |
103,521,769 |
RGD:6480464 |
CTD |
| G |
Map2 |
microtubule-associated protein 2 |
|
decreases expression |
ISO |
9 |
65,174,376 |
65,256,003 |
RGD:6480464 |
CTD |
| G |
Map2 |
microtubule-associated protein 2 |
|
decreases expression |
ISO |
9 |
65,174,376 |
65,256,003 |
RGD:6480464 |
CTD |
| G |
Map2 |
microtubule-associated protein 2 |
|
decreases expression |
ISO |
9 |
65,174,376 |
65,256,003 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
affects expression |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
affects expression |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk15 |
mitogen-activated protein kinase 15 |
|
increases expression |
EXP |
7 |
114,026,694 |
114,032,007 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
increases expression |
ISO |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
multiple interactions |
EXP |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
decreases expression |
EXP |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
March11 |
membrane-associated ring finger (C3HC4) 11 |
|
decreases expression |
EXP |
2 |
77,989,651 |
78,090,956 |
RGD:6480464 |
CTD |
| G |
Mbnl3 |
muscleblind-like splicing regulator 3 |
|
affects expression |
EXP |
X |
137,891,633 |
137,941,868 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
increases expression |
ISO |
4 |
175,248,654 |
175,263,881 |
RGD:6480464 |
CTD |
| G |
Mmp10 |
matrix metallopeptidase 10 (stromelysin 2) |
|
increases expression |
ISO |
8 |
4,367,842 |
4,375,737 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
increases expression |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mogat1 |
monoacylglycerol O-acyltransferase 1 |
|
decreases expression |
EXP |
9 |
77,901,139 |
77,908,689 |
RGD:6480464 |
CTD |
| G |
Mrpl19 |
mitochondrial ribosomal protein L19 |
|
decreases expression |
EXP |
4 |
116,207,542 |
116,211,771 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mthfd2l |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like |
|
decreases expression |
EXP |
14 |
18,585,147 |
18,665,534 |
RGD:6480464 |
CTD |
| G |
Mtrr |
5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
|
decreases expression |
EXP |
17 |
5,086,219 |
5,118,086 |
RGD:6480464 |
CTD |
| G |
Mutyh |
mutY homolog (E. coli) |
|
increases expression |
EXP |
5 |
137,103,958 |
137,115,897 |
RGD:6480464 |
CTD |
| G |
Nanog |
Nanog homeobox |
|
increases expression |
ISO |
4 |
159,190,786 |
159,198,160 |
RGD:6480464 |
CTD |
| G |
Ndn |
necdin, melanoma antigen (MAGE) family member |
|
affects expression |
ISO |
1 |
116,594,603 |
116,596,202 |
RGD:6480464 |
CTD |
| G |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
18 |
61,134,242 |
61,477,040 |
RGD:6480464 |
CTD |
| G |
Nefh |
neurofilament, heavy polypeptide |
|
decreases expression |
EXP |
14 |
85,594,789 |
85,604,774 |
RGD:6480464 |
CTD |
| G |
Nefl |
neurofilament, light polypeptide |
|
affects expression |
ISO |
15 |
47,636,303 |
47,640,176 |
RGD:6480464 |
CTD |
| G |
Nefl |
neurofilament, light polypeptide |
|
decreases expression |
EXP |
15 |
47,636,303 |
47,640,176 |
RGD:6480464 |
CTD |
| G |
Nell2 |
NEL-like 2 (chicken) |
|
increases expression |
ISO |
7 |
133,758,271 |
134,080,104 |
RGD:6480464 |
CTD |
| G |
Nes |
nestin |
|
affects expression |
EXP |
2 |
180,051,907 |
180,060,947 |
RGD:6480464 |
CTD |
| G |
Nes |
nestin |
|
increases expression |
EXP |
2 |
180,051,907 |
180,060,947 |
RGD:6480464 |
CTD |
| G |
Nes |
nestin |
|
increases expression |
ISO |
2 |
180,051,907 |
180,060,947 |
RGD:6480464 |
CTD |
| G |
Neurog2 |
neurogenin 2 |
|
affects expression |
ISO |
2 |
224,896,395 |
224,897,186 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
affects localization |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases expression |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
decreases response to substance |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
affects localization |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nkx6-1 |
NK6 homeobox 1 |
|
affects expression |
EXP |
14 |
9,214,743 |
9,221,676 |
RGD:6480464 |
CTD |
| G |
Nkx6-2 |
NK6 homeobox 2 |
|
affects expression |
EXP |
1 |
199,397,361 |
199,398,901 |
RGD:6480464 |
CTD |
| G |
Nmur1 |
neuromedin U receptor 1 |
|
decreases expression |
ISO |
9 |
85,146,808 |
85,148,380 |
RGD:6480464 |
CTD |
| G |
Nodal |
nodal growth differentiation factor |
|
increases expression |
ISO |
20 |
29,546,982 |
29,555,419 |
RGD:6480464 |
CTD |
| G |
Nodal |
nodal growth differentiation factor |
|
increases expression |
ISO |
20 |
29,546,982 |
29,555,419 |
RGD:6480464 |
CTD |
| G |
Notch1 |
notch 1 |
|
affects expression |
EXP |
3 |
4,631,797 |
4,677,640 |
RGD:6480464 |
CTD |
| G |
Npy4r |
neuropeptide Y receptor Y4 |
|
decreases expression |
ISO |
16 |
9,787,170 |
9,788,426 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo2 |
NAD(P)H dehydrogenase, quinone 2 |
|
decreases expression |
ISO |
17 |
37,255,630 |
37,283,753 |
RGD:6480464 |
CTD |
| G |
Nr2f6 |
nuclear receptor subfamily 2, group F, member 6 |
|
affects expression |
ISO |
16 |
18,535,181 |
18,542,627 |
RGD:6480464 |
CTD |
| G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
|
affects expression |
ISO |
3 |
38,866,205 |
38,871,678 |
RGD:6480464 |
CTD |
| G |
Nrf1 |
nuclear respiratory factor 1 |
|
decreases expression |
EXP |
4 |
56,949,553 |
57,048,149 |
RGD:6480464 |
CTD |
| G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
|
affects expression |
ISO |
17 |
11,494,463 |
11,811,654 |
RGD:6480464 |
CTD |
| G |
Ntsr1 |
neurotensin receptor 1 |
|
decreases expression |
ISO |
3 |
169,567,488 |
169,633,121 |
RGD:6480464 |
CTD |
| G |
Nuf2 |
NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
decreases expression |
ISO |
13 |
85,286,634 |
85,315,366 |
RGD:6480464 |
CTD |
| G |
Olig1 |
oligodendrocyte transcription factor 1 |
|
increases expression |
ISO |
11 |
31,244,279 |
31,246,421 |
RGD:6480464 |
CTD |
| G |
Olig1 |
oligodendrocyte transcription factor 1 |
|
increases expression |
ISO |
11 |
31,244,279 |
31,246,421 |
RGD:6480464 |
CTD |
| G |
Olig2 |
oligodendrocyte lineage transcription factor 2 |
|
decreases expression |
ISO |
11 |
31,205,416 |
31,208,792 |
RGD:6480464 |
CTD |
| G |
Olig2 |
oligodendrocyte lineage transcription factor 2 |
|
increases expression |
ISO |
11 |
31,205,416 |
31,208,792 |
RGD:6480464 |
CTD |
| G |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
|
increases expression |
ISO |
19 |
49,675,215 |
49,690,479 |
RGD:6480464 |
CTD |
| G |
Ovol2 |
ovo-like 2 (Drosophila) |
|
affects expression |
ISO |
3 |
132,842,267 |
132,871,206 |
RGD:6480464 |
CTD |
| G |
Oxsr1 |
oxidative-stress responsive 1 |
|
increases expression |
EXP |
8 |
124,196,599 |
124,286,647 |
RGD:6480464 |
CTD |
| G |
Park2 |
parkinson protein 2, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
1 |
43,151,265 |
44,374,470 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pax3 |
paired box 3 |
|
affects expression |
ISO |
9 |
77,477,813 |
77,576,632 |
RGD:6480464 |
CTD |
| G |
Pax6 |
paired box 6 |
|
affects expression |
ISO |
3 |
91,127,605 |
91,149,178 |
RGD:6480464 |
CTD |
| G |
Pax6 |
paired box 6 |
|
decreases expression |
ISO |
3 |
91,127,605 |
91,149,178 |
RGD:6480464 |
CTD |
| G |
Pcdh8 |
protocadherin 8 |
|
affects expression |
EXP |
15 |
61,056,994 |
61,060,741 |
RGD:6480464 |
CTD |
| G |
Pcsk9 |
proprotein convertase subtilisin/kexin type 9 |
|
affects expression |
ISO |
5 |
127,501,476 |
127,524,289 |
RGD:6480464 |
CTD |
| G |
Pde11a |
phosphodiesterase 11A |
|
decreases expression |
EXP |
3 |
58,659,595 |
59,049,869 |
RGD:6480464 |
CTD |
| G |
Pde5a |
phosphodiesterase 5A, cGMP-specific |
|
decreases expression |
EXP |
2 |
219,410,394 |
219,550,910 |
RGD:6480464 |
CTD |
| G |
Pdhx |
pyruvate dehydrogenase complex, component X |
|
decreases expression |
EXP |
3 |
88,240,250 |
88,270,914 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
EXP |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pigr |
polymeric immunoglobulin receptor |
|
increases expression |
ISO |
13 |
43,785,845 |
43,819,331 |
RGD:6480464 |
CTD |
| G |
Pik3r1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
affects expression |
EXP |
2 |
32,602,673 |
32,675,350 |
RGD:6480464 |
CTD |
| G |
Pira3 |
paired-Ig-like receptor A3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pitx2 |
paired-like homeodomain 2 |
|
decreases expression |
EXP |
2 |
226,581,170 |
226,601,319 |
RGD:6480464 |
CTD |
| G |
Pou4f2 |
POU class 4 homeobox 2 |
|
affects expression |
ISO |
19 |
31,388,907 |
31,392,548 |
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU class 5 homeobox 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Prdm1 |
PR domain containing 1, with ZNF domain |
|
affects expression |
ISO |
20 |
48,438,224 |
48,459,848 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
increases expression |
ISO |
5 |
136,975,780 |
136,991,630 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
increases expression |
ISO |
5 |
136,975,780 |
136,991,630 |
RGD:6480464 |
CTD |
| G |
Prdx1l1 |
peroxiredoxin 1-like 1 |
|
increases expression |
ISO |
2 |
201,373,420 |
201,374,019 |
RGD:6480464 |
CTD |
| G |
Prokr1 |
prokineticin receptor 1 |
|
decreases expression |
ISO |
4 |
121,750,651 |
121,758,116 |
RGD:6480464 |
CTD |
| G |
Prorsd1 |
prolyl-tRNA synthetase associated domain containing 1 |
|
decreases expression |
EXP |
14 |
110,530,889 |
110,533,157 |
RGD:6480464 |
CTD |
| G |
Psmb8 |
proteasome (prosome, macropain) subunit, beta type, 8 |
|
decreases expression |
ISO |
20 |
4,786,260 |
4,789,223 |
RGD:6480464 |
CTD |
| G |
Psmb9 |
proteasome (prosome, macropain) subunit, beta type, 9 |
|
decreases expression |
ISO |
20 |
4,801,187 |
4,806,608 |
RGD:6480464 |
CTD |
| G |
Psme1 |
proteasome (prosome, macropain) activator subunit 1 |
|
decreases expression |
ISO |
15 |
33,712,892 |
33,715,769 |
RGD:6480464 |
CTD |
| G |
Ptgfrn |
prostaglandin F2 receptor inhibitor |
|
increases expression |
EXP |
2 |
196,091,505 |
196,162,950 |
RGD:6480464 |
CTD |
| G |
Ptpla |
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member a |
|
decreases expression |
EXP |
17 |
88,239,568 |
88,253,571 |
RGD:6480464 |
CTD |
| G |
Pttg1ip |
pituitary tumor-transforming 1 interacting protein |
|
decreases expression |
ISO |
20 |
11,414,678 |
11,431,939 |
RGD:6480464 |
CTD |
| G |
Pwp2 |
PWP2 periodic tryptophan protein homolog (yeast) |
|
decreases expression |
EXP |
20 |
10,836,094 |
10,849,727 |
RGD:6480464 |
CTD |
| G |
Qrsl1 |
glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1 |
|
decreases expression |
EXP |
20 |
47,793,416 |
47,818,351 |
RGD:6480464 |
CTD |
| G |
Rab3ip |
RAB3A interacting protein |
|
increases expression |
EXP |
7 |
56,229,363 |
56,258,007 |
RGD:6480464 |
CTD |
| G |
Rabgef1 |
RAB guanine nucleotide exchange factor (GEF) 1 |
|
decreases expression |
EXP |
12 |
27,497,545 |
27,525,385 |
RGD:6480464 |
CTD |
| G |
Rabl3 |
RAB, member of RAS oncogene family-like 3 |
|
decreases expression |
EXP |
11 |
64,943,199 |
64,972,157 |
RGD:6480464 |
CTD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
decreases expression |
EXP |
12 |
11,380,314 |
11,400,531 |
RGD:6480464 |
CTD |
| G |
Rbm12 |
RNA binding motif protein 12 |
|
decreases expression |
EXP |
3 |
146,504,101 |
146,521,424 |
RGD:6480464 |
CTD |
| G |
Rerg |
RAS-like, estrogen-regulated, growth-inhibitor |
|
affects expression |
EXP |
4 |
174,125,313 |
174,140,346 |
RGD:6480464 |
CTD |
| G |
RGD1309077 |
similar to putative RNA methyltransferase |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
RGD1562301 |
similar to glutaminyl-tRNA synthetase |
|
increases expression |
EXP |
8 |
113,556,500 |
113,563,232 |
RGD:6480464 |
CTD |
| G |
RGD1563084 |
similar to FLJ20298 protein isoform a |
|
increases expression |
EXP |
X |
127,388,586 |
127,484,707 |
RGD:6480464 |
CTD |
| G |
Rhebl1 |
Ras homolog enriched in brain like 1 |
|
increases expression |
EXP |
7 |
137,645,541 |
137,649,476 |
RGD:6480464 |
CTD |
| G |
Rhoa |
ras homolog family member A |
|
decreases response to substance |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rhoa |
ras homolog family member A |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rhox9 |
reproductive homeobox 9 |
|
increases expression |
ISO |
X |
7,496,685 |
7,499,536 |
RGD:6480464 |
CTD |
| G |
Rims2 |
regulating synaptic membrane exocytosis 2 |
|
decreases expression |
EXP |
7 |
74,757,003 |
75,271,771 |
RGD:6480464 |
CTD |
| G |
Rin2 |
Ras and Rab interactor 2 |
|
decreases expression |
ISO |
3 |
134,307,538 |
134,503,915 |
RGD:6480464 |
CTD |
| G |
Rnf166 |
ring finger protein 166 |
|
increases expression |
EXP |
19 |
52,755,818 |
52,765,658 |
RGD:6480464 |
CTD |
| G |
Robo3 |
roundabout, axon guidance receptor, homolog 3 (Drosophila) |
|
affects expression |
EXP |
8 |
38,668,913 |
38,683,439 |
RGD:6480464 |
CTD |
| G |
Rpia |
ribose 5-phosphate isomerase A |
|
decreases expression |
EXP |
4 |
103,934,938 |
103,960,574 |
RGD:6480464 |
CTD |
| G |
RT1-S3 |
RT1 class Ib, locus S3 |
|
affects expression |
ISO |
20 |
2,815,943 |
2,820,644 |
RGD:6480464 |
CTD |
| G |
Rtn4rl2 |
reticulon 4 receptor-like 2 |
|
affects expression |
ISO |
3 |
68,098,435 |
68,113,874 |
RGD:6480464 |
CTD |
| G |
Rwdd2b |
RWD domain containing 2B |
|
decreases expression |
EXP |
11 |
27,189,244 |
27,197,900 |
RGD:6480464 |
CTD |
| G |
S100b |
S100 calcium binding protein B |
|
increases expression |
EXP |
20 |
12,791,440 |
12,824,508 |
RGD:6480464 |
CTD |
| G |
S1pr5 |
sphingosine-1-phosphate receptor 5 |
|
affects expression |
EXP |
8 |
20,278,404 |
20,283,375 |
RGD:6480464 |
CTD |
| G |
Sae1 |
SUMO1 activating enzyme subunit 1 |
|
decreases expression |
ISO |
1 |
76,584,876 |
76,640,465 |
RGD:6480464 |
CTD |
| G |
Serpinb2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
|
increases expression |
ISO |
13 |
13,632,596 |
13,641,605 |
RGD:6480464 |
CTD |
| G |
Sharpin |
SHANK-associated RH domain interactor |
|
increases expression |
EXP |
7 |
114,397,762 |
114,401,974 |
RGD:6480464 |
CTD |
| G |
Shh |
sonic hedgehog |
|
decreases expression |
ISO |
4 |
2,200,504 |
2,209,657 |
RGD:6480464 |
CTD |
| G |
Skp1 |
S-phase kinase-associated protein 1 |
|
increases expression |
ISO |
10 |
37,665,417 |
37,680,338 |
RGD:6480464 |
CTD |
| G |
Slc17a5 |
solute carrier family 17 (anion/sugar transporter), member 5 |
|
increases expression |
EXP |
8 |
83,516,448 |
83,551,409 |
RGD:6480464 |
CTD |
| G |
Slc22a12 |
solute carrier family 22 (organic anion/urate transporter), member 12 |
|
decreases expression |
ISO |
1 |
209,320,804 |
209,327,918 |
RGD:6480464 |
CTD |
| G |
Slc24a6 |
solute carrier family 24 (sodium/lithium/calcium exchanger), member 6 |
|
increases expression |
EXP |
12 |
37,227,844 |
37,250,698 |
RGD:6480464 |
CTD |
| G |
Slc25a37 |
solute carrier family 25 (mitochondrial iron transporter), member 37 |
|
decreases expression |
EXP |
15 |
49,806,324 |
49,846,988 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
increases expression |
ISO |
5 |
139,690,801 |
139,719,021 |
RGD:6480464 |
CTD |
| G |
Slc30a10 |
solute carrier family 30, member 10 |
|
increases expression |
ISO |
13 |
101,474,867 |
101,492,180 |
RGD:6480464 |
CTD |
| G |
Slc30a7 |
solute carrier family 30 (zinc transporter), member 7 |
|
decreases expression |
EXP |
2 |
212,088,266 |
212,162,896 |
RGD:6480464 |
CTD |
| G |
Slc7a11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
multiple interactions |
EXP |
2 |
139,241,142 |
139,317,101 |
RGD:6480464 |
CTD |
| G |
Slitrk5 |
SLIT and NTRK-like family, member 5 |
|
affects expression |
ISO |
15 |
96,407,553 |
96,412,374 |
RGD:6480464 |
CTD |
| G |
Smad3 |
SMAD family member 3 |
|
increases expression |
ISO |
8 |
67,803,909 |
67,952,056 |
RGD:6480464 |
CTD |
| G |
Smad4 |
SMAD family member 4 |
|
increases expression |
ISO |
18 |
70,432,705 |
70,461,541 |
RGD:6480464 |
CTD |
| G |
Smarca4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
|
affects expression |
EXP |
8 |
20,720,915 |
20,812,157 |
RGD:6480464 |
CTD |
| G |
Smurf1 |
SMAD specific E3 ubiquitin protein ligase 1 |
|
increases expression |
ISO |
12 |
9,950,304 |
10,042,391 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
decreases expression |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Sncaip |
synuclein, alpha interacting protein |
|
increases expression |
ISO |
18 |
48,122,804 |
48,259,575 |
RGD:6480464 |
CTD |
| G |
Snx3 |
sorting nexin 3 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sox10 |
SRY (sex determining region Y)-box 10 |
|
decreases expression |
EXP |
7 |
117,138,694 |
117,149,939 |
RGD:6480464 |
CTD |
| G |
Sqstm1 |
sequestosome 1 |
|
increases expression |
EXP |
10 |
35,751,300 |
35,762,630 |
RGD:6480464 |
CTD |
| G |
Sstr3 |
somatostatin receptor 3 |
|
decreases expression |
ISO |
7 |
116,495,750 |
116,502,948 |
RGD:6480464 |
CTD |
| G |
Stard4 |
StAR-related lipid transfer (START) domain containing 4 |
|
decreases expression |
EXP |
18 |
25,638,433 |
25,653,958 |
RGD:6480464 |
CTD |
| G |
Stim1 |
stromal interaction molecule 1 |
|
increases expression |
EXP |
1 |
159,761,567 |
159,925,836 |
RGD:6480464 |
CTD |
| G |
Stmn3 |
stathmin-like 3 |
|
affects expression |
ISO |
3 |
170,446,808 |
170,454,900 |
RGD:6480464 |
CTD |
| G |
Syp |
synaptophysin |
|
decreases expression |
ISO |
X |
26,890,307 |
26,905,319 |
RGD:6480464 |
CTD |
| G |
Tacr2 |
tachykinin receptor 2 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tacr3 |
tachykinin receptor 3 |
|
decreases expression |
ISO |
2 |
232,309,015 |
232,404,964 |
RGD:6480464 |
CTD |
| G |
Taf1d |
TATA box binding protein (Tbp)-associated factor, RNA polymerase I, D |
|
decreases expression |
EXP |
8 |
12,107,144 |
12,117,177 |
RGD:6480464 |
CTD |
| G |
Tbrg4 |
transforming growth factor beta regulator 4 |
|
decreases expression |
EXP |
14 |
87,372,275 |
87,378,266 |
RGD:6480464 |
CTD |
| G |
Tbx3 |
T-box 3 |
|
affects expression |
ISO |
12 |
38,155,494 |
38,166,670 |
RGD:6480464 |
CTD |
| G |
Tbx6 |
T-box 6 |
|
decreases expression |
ISO |
1 |
185,957,068 |
185,960,977 |
RGD:6480464 |
CTD |
| G |
Tcf15 |
transcription factor 15 |
|
affects expression |
ISO |
3 |
142,491,664 |
142,497,446 |
RGD:6480464 |
CTD |
| G |
Tdgf1 |
teratocarcinoma-derived growth factor 1 |
|
affects expression |
ISO |
8 |
115,341,587 |
115,346,871 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Tjp3 |
tight junction protein 3 |
|
decreases expression |
ISO |
7 |
9,917,359 |
9,930,081 |
RGD:6480464 |
CTD |
| G |
Tlcd1 |
TLC domain containing 1 |
|
decreases expression |
EXP |
10 |
64,454,775 |
64,456,808 |
RGD:6480464 |
CTD |
| G |
Tmed5 |
transmembrane emp24 protein transport domain containing 5 |
|
decreases expression |
EXP |
14 |
2,155,594 |
2,167,280 |
RGD:6480464 |
CTD |
| G |
Tmem69 |
transmembrane protein 69 |
|
decreases expression |
EXP |
5 |
136,831,040 |
136,834,619 |
RGD:6480464 |
CTD |
| G |
Tnfaip8l1 |
tumor necrosis factor, alpha-induced protein 8-like 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnfrsf19 |
tumor necrosis factor receptor superfamily, member 19 |
|
increases expression |
EXP |
15 |
40,051,695 |
40,117,968 |
RGD:6480464 |
CTD |
| G |
Tnks2 |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2 |
|
increases expression |
EXP |
1 |
241,112,141 |
241,164,804 |
RGD:6480464 |
CTD |
| G |
Toe1 |
target of EGR1, member 1 (nuclear) |
|
decreases expression |
ISO |
5 |
137,100,321 |
137,103,886 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
decreases expression |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Tp63 |
tumor protein p63 |
|
affects expression |
EXP |
11 |
76,900,622 |
77,200,251 |
RGD:6480464 |
CTD |
| G |
Tpcn2 |
two pore segment channel 2 |
|
decreases expression |
ISO |
1 |
205,702,971 |
205,732,664 |
RGD:6480464 |
CTD |
| G |
Tpra1 |
transmembrane protein, adipocyte asscociated 1 |
|
increases expression |
EXP |
4 |
123,001,474 |
123,006,178 |
RGD:6480464 |
CTD |
| G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
|
decreases expression |
ISO |
8 |
100,770,833 |
100,821,420 |
RGD:6480464 |
CTD |
| G |
Tsc1 |
tuberous sclerosis 1 |
|
affects expression |
ISO |
3 |
7,645,313 |
7,672,944 |
RGD:6480464 |
CTD |
| G |
Ttc3 |
tetratricopeptide repeat domain 3 |
|
increases expression |
ISO |
11 |
34,617,072 |
34,659,043 |
RGD:6480464 |
CTD |
| G |
Tubb3 |
tubulin, beta 3 class III |
|
decreases expression |
ISO |
19 |
53,742,652 |
53,751,706 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
decreases activity |
EXP |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
decreases expression |
EXP |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Tyw5 |
tRNA-yW synthesizing protein 5 |
|
decreases expression |
EXP |
9 |
56,283,826 |
56,302,571 |
RGD:6480464 |
CTD |
| G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
|
decreases expression |
ISO |
3 |
155,800,357 |
155,802,757 |
RGD:6480464 |
CTD |
| G |
Ube2f |
ubiquitin-conjugating enzyme E2F (putative) |
|
increases expression |
ISO |
9 |
90,480,334 |
90,515,912 |
RGD:6480464 |
CTD |
| G |
Ube2i |
ubiquitin-conjugating enzyme E2I |
|
increases expression |
ISO |
10 |
14,509,948 |
14,524,551 |
RGD:6480464 |
CTD |
| G |
Ube2j1 |
ubiquitin-conjugating enzyme E2, J1 |
|
increases expression |
ISO |
5 |
49,317,881 |
49,337,258 |
RGD:6480464 |
CTD |
| G |
Ube2k |
ubiquitin-conjugating enzyme E2K |
|
increases expression |
ISO |
14 |
45,349,287 |
45,411,823 |
RGD:6480464 |
CTD |
| G |
Ube2l6 |
ubiquitin-conjugating enzyme E2L 6 |
|
decreases expression |
ISO |
3 |
68,000,239 |
68,016,331 |
RGD:6480464 |
CTD |
| G |
Ube2t |
ubiquitin-conjugating enzyme E2T (putative) |
|
decreases expression |
ISO |
13 |
47,924,340 |
47,934,842 |
RGD:6480464 |
CTD |
| G |
Ube2w |
ubiquitin-conjugating enzyme E2W |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ube2wl |
ubiquitin-conjugating enzyme E2W-like |
|
increases expression |
ISO |
X |
29,818,682 |
29,824,530 |
RGD:6480464 |
CTD |
| G |
Ubiad1 |
UbiA prenyltransferase domain containing 1 |
|
decreases expression |
EXP |
5 |
165,515,219 |
165,526,817 |
RGD:6480464 |
CTD |
| G |
Uchl1 |
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
|
increases expression |
ISO |
14 |
44,114,392 |
44,124,947 |
RGD:6480464 |
CTD |
| G |
Ufd1l |
ubiquitin fusion degradation 1 like (yeast) |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Usp11 |
ubiquitin specific peptidase 11 |
|
increases expression |
EXP |
X |
12,890,515 |
12,906,686 |
RGD:6480464 |
CTD |
| G |
Usp38 |
ubiquitin specific peptidase 38 |
|
increases expression |
ISO |
19 |
28,847,283 |
28,879,605 |
RGD:6480464 |
CTD |
| G |
Utp18 |
UTP18, small subunit (SSU) processome component, homolog (yeast) |
|
decreases expression |
EXP |
10 |
82,515,696 |
82,542,665 |
RGD:6480464 |
CTD |
| G |
Vasp |
vasodilator-stimulated phosphoprotein |
|
affects expression |
ISO |
1 |
78,621,494 |
78,636,762 |
RGD:6480464 |
CTD |
| G |
Vwf |
von Willebrand factor |
|
affects expression |
EXP |
4 |
161,723,415 |
161,854,766 |
RGD:6480464 |
CTD |
| G |
Wdr43 |
WD repeat domain 43 |
|
decreases expression |
EXP |
6 |
23,950,923 |
23,990,272 |
RGD:6480464 |
CTD |
| G |
Wee1 |
wee 1 homolog (S. pombe) |
|
decreases expression |
ISO |
1 |
167,769,797 |
167,788,199 |
RGD:6480464 |
CTD |
| G |
Wnt1 |
wingless-type MMTV integration site family, member 1 |
|
affects expression |
ISO |
7 |
137,557,836 |
137,561,883 |
RGD:6480464 |
CTD |
| G |
Wnt1 |
wingless-type MMTV integration site family, member 1 |
|
decreases expression |
ISO |
7 |
137,557,836 |
137,561,883 |
RGD:6480464 |
CTD |
| G |
Xirp1 |
xin actin-binding repeat containing 1 |
|
affects expression |
EXP |
8 |
124,995,308 |
125,001,397 |
RGD:6480464 |
CTD |
| G |
Xkr5 |
XK, Kell blood group complex subunit-related family, member 5 |
|
decreases expression |
EXP |
16 |
75,677,746 |
75,695,654 |
RGD:6480464 |
CTD |
| G |
Zfp276 |
zinc finger protein (C2H2 type) 276 |
|
decreases expression |
EXP |
19 |
53,575,020 |
53,588,068 |
RGD:6480464 |
CTD |
| G |
Zfp292 |
zinc finger protein 292 |
|
decreases expression |
ISO |
5 |
51,438,560 |
51,518,820 |
RGD:6480464 |
CTD |
| G |
Zfp553 |
zinc finger protein 553 |
|
decreases expression |
EXP |
1 |
186,497,357 |
186,501,551 |
RGD:6480464 |
CTD |
| G |
Zfp819 |
zinc finger protein 819 |
|
decreases expression |
EXP |
1 |
94,009,048 |
94,019,562 |
RGD:6480464 |
CTD |
| G |
Zkscan5 |
zinc finger with KRAB and SCAN domains 5 |
|
decreases expression |
ISO |
12 |
9,697,741 |
9,718,773 |
RGD:6480464 |
CTD |
Term paths to the root
|